All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

  TRANSLATE

The gvhd Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the gvhd Hub cannot guarantee the accuracy of translated content. The gvhd and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.

Now you can support HCPs in making informed decisions for their patients

Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.

Find out more

Outpatient surveillance blood cultures in patients with acute graft-versus-host disease receiving high-dose steroids

By Anna Bartus

Share:

Feb 13, 2019


On 31 January 2019, Erica Stohs from the Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA, and colleagues published in the Biology of Blood and Marrow Transplantation, the results of a retrospective study assessing the value of weekly surveillance blood cultures (SBCs) drawn in an outpatient setting from patients receiving hematopoietic cell transplant (HCT) and high-dose steroids. The researchers hypothesized that all positive outpatient surveillance cultures would be low-pathogenicity gram positive bacteria which would lead to additional vancomycin therapy.

Patients and methods

  • N = 127 patients undergoing transplantation
  • Median age: 52 years (range, 41–59)
  • Blood cultures were collected and analyzed
  • Patients were treated with a high-dose of steroids (prednisone-equivalent doses ≥ 0.5 mg/kg/day) for acute graft-versus-host disease (GvHD)
  • Initial glucocorticoid dose:
    • 2 mg/kg/day, n = 26 (21%)
    • 1 mg/kg/day, n = 65 (46%)
    • 5 mg/kg/day, n = 36 (28%)
  • SBCs were taken weekly from central venous catheters (CVCs) in the outpatient setting

Key findings

  • N = 1015 SBCs were collected and analyzed
  • N = 97 patients (76%) had no positive cultures
  • N = 26 patients (20%) had one positive culture
  • N = 4 patients (3%) had > 1 positive culture
  • N = 42 bacteria were isolated from 36/1015 cultures (3.5%) in 30 unique patients
  • Coagulase-negative Staphylococcus was the most frequently observed organism: 25/1015 (2.5%)
  • Gram-negative organisms were rarely detected: 4/1015 (0.4%)
  • Most patients received antibiotics with positive surveillance cultures: 33/36 (92%)
  • Six patients were hospitalized for treatment
  • Vancomycin was the most frequently used antibiotic: 256/376 (68%) total days of antibiotic was administered with a median duration of 10 days (range, 7–14)

In summary, weekly outpatient SBCs collected from asymptomatic patients receiving high-dose steroids for the treatment of acute GvHD after HCT were found to be infrequently positive. The authors added that “surveillance blood cultures also led to excess antibiotic exposure and costs, suggesting benefits of such ambulatory screening may be of limited value in this setting.”

References

Your opinion matters

When would you be most likely to consider prescribing belumosudil third-line and beyond?